“Selective GABAB receptor antagonist, CGP-55845, promotes remyelination and oligodendrocyte differentiation in rats with experimental autoimmune encephalomyelitis (EAE)” (2026) Journal of Biological Regulators and Homeostatic Agents, 40(1), p. 3807. doi:10.54517/jbrha3807.